Search research articles
Contact Us
Filters
Showing results (51-60 of 66) with videos related to
Page
of 7
Sort By:
Neuroimage
|
December 15, 2015
ENIGMA and the individual: Predicting factors that affect the brain in 35 countries worldwide
Paul M Thompson, Ole A Andreassen, Alejandro Arias-Vasquez, et al.
Schizophrenia Research
|
October 7, 2017
The Genetics of Endophenotypes of Neurofunction to Understand Schizophrenia (GENUS) consortium: A collaborative cognitive and neuroimaging genetics project
Gabriëlla A M Blokland, Elisabetta C Del Re, Raquelle I Mesholam-Gately, et al.
Schizophrenia Bulletin Open
|
August 27, 2025
Sample Ascertainment and Recruitment Sources in the Accelerating Medicines Partnership Schizophrenia Program
Jean Addington, Amy Shalev, Lu Liu, et al.
Schizophrenia Bulletin Open
|
August 27, 2025
Baseline Clinical Characterization of Participants in the Accelerating Medicines Partnership Schizophrenia Program
Jean Addington, Lu Liu, Monica Chu, et al.
Translational Psychiatry
|
May 31, 2020
ENIGMA MDD: seven years of global neuroimaging studies of major depression through worldwide data sharing
Lianne Schmaal, Elena Pozzi, Tiffany C Ho, et al.
Schizophrenia Bulletin
|
May 11, 2026
Premorbid adjustment problems, negative symptoms, and cognitive impairment in a large international sample at clinical high risk for psychosis: Findings from the Accelerating Medicines Partnership-Schizophrenia
Henry R Cowan, Danielle Pratt, Jai L Shah, et al.
Schizophrenia (Heidelberg, Germany)
|
March 25, 2025
Cognitive assessment in the Accelerating Medicines Partnership® Schizophrenia Program: harmonization priorities and strategies in a diverse international sample
Kelly Allott, Walid Yassin, Luis Alameda, et al.
Molecular Psychiatry
|
December 21, 2019
Altered white matter microstructural organization in posttraumatic stress disorder across 3047 adults: results from the PGC-ENIGMA PTSD consortium
Emily L Dennis, Seth G Disner, Negar Fani, et al.
Biological Psychiatry
|
November 25, 2018
Reply to: New Meta- and Mega-analyses of Magnetic Resonance Imaging Findings in Schizophrenia: Do They Really Increase Our Knowledge About the Nature of the Disease Process?
Theo G M van Erp, Esther Walton, Derrek P Hibar, et al.
Molecular Psychiatry
|
February 2, 2019
Correction: Dose response of the 16p11.2 distal copy number variant on intracranial volume and basal ganglia
Ida E Sønderby, Ómar Gústafsson, Nhat Trung Doan, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 66) with videos related to
Sort By:
Page
of 7
Neuroimage
|
December 15, 2015
ENIGMA and the individual: Predicting factors that affect the brain in 35 countries worldwide
Paul M Thompson, Ole A Andreassen, Alejandro Arias-Vasquez, et al.
Schizophrenia Research
|
October 7, 2017
The Genetics of Endophenotypes of Neurofunction to Understand Schizophrenia (GENUS) consortium: A collaborative cognitive and neuroimaging genetics project
Gabriëlla A M Blokland, Elisabetta C Del Re, Raquelle I Mesholam-Gately, et al.
Schizophrenia Bulletin Open
|
August 27, 2025
Sample Ascertainment and Recruitment Sources in the Accelerating Medicines Partnership Schizophrenia Program
Jean Addington, Amy Shalev, Lu Liu, et al.
Schizophrenia Bulletin Open
|
August 27, 2025
Baseline Clinical Characterization of Participants in the Accelerating Medicines Partnership Schizophrenia Program
Jean Addington, Lu Liu, Monica Chu, et al.
Translational Psychiatry
|
May 31, 2020
ENIGMA MDD: seven years of global neuroimaging studies of major depression through worldwide data sharing
Lianne Schmaal, Elena Pozzi, Tiffany C Ho, et al.
Schizophrenia Bulletin
|
May 11, 2026
Premorbid adjustment problems, negative symptoms, and cognitive impairment in a large international sample at clinical high risk for psychosis: Findings from the Accelerating Medicines Partnership-Schizophrenia
Henry R Cowan, Danielle Pratt, Jai L Shah, et al.
Schizophrenia (Heidelberg, Germany)
|
March 25, 2025
Cognitive assessment in the Accelerating Medicines Partnership® Schizophrenia Program: harmonization priorities and strategies in a diverse international sample
Kelly Allott, Walid Yassin, Luis Alameda, et al.
Molecular Psychiatry
|
December 21, 2019
Altered white matter microstructural organization in posttraumatic stress disorder across 3047 adults: results from the PGC-ENIGMA PTSD consortium
Emily L Dennis, Seth G Disner, Negar Fani, et al.
Biological Psychiatry
|
November 25, 2018
Reply to: New Meta- and Mega-analyses of Magnetic Resonance Imaging Findings in Schizophrenia: Do They Really Increase Our Knowledge About the Nature of the Disease Process?
Theo G M van Erp, Esther Walton, Derrek P Hibar, et al.
Molecular Psychiatry
|
February 2, 2019
Correction: Dose response of the 16p11.2 distal copy number variant on intracranial volume and basal ganglia
Ida E Sønderby, Ómar Gústafsson, Nhat Trung Doan, et al.
Page
of 7